Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Kabronon Apr 01, 2021 9:56am
114 Views
Post# 32922020

RE:For Dummies

RE:For DummiesI believe the expectation was as of Apr 1st if you wanted to get an Aristotle test you would contact the company, a blood sample would be provided and you would then get a positive or negative result. Now the company is saying it is a 3 step process (or some sht like that) where you get enrolled into an arisolte program..where you would have to be screened by a specialist, I guess then decided to get the test done and if negative ..nothing...if positive, then would refer you. Just a longer process... in thr long run this will make company more money as they will.charge for all 3 steps. What confused me was he said as of Monday you can enroll in this program..but with Atkinson he said there are still some crossing it's and dotting i's left to do with Aristotle which is causing the confusion. I might be way off .... if so someone correct me as I think alot of ppl are confused a bit.
<< Previous
Bullboard Posts
Next >>